• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACS¿ LYSE WASH ASSISTANT; STATION, PIPETTING DILUTING CLINICAL USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACS¿ LYSE WASH ASSISTANT; STATION, PIPETTING DILUTING CLINICAL USE Back to Search Results
Model Number 337146
Device Problem Contamination (1120)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/22/2021
Event Type  malfunction  
Manufacturer Narrative
Medical device expiration date: na.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the bd facs¿ lyse wash assistant carried over contamination between samples.There was no adverse patient impact.The following information was provided by the initial reporter: "customer suspects a contamination between samples that is observable when acquiring tubes with the facscanto.The cytometer is clean and cst passes fine." were samples contaminated? yes.Are there erroneous results on patient samples for diagnostic test? no.Was there any delay of treatment due to the issue? no.If patient samples were redrawn, was there any change or delay of treatment? no.Was there any physical harm/injury to the patient due to the issue? no.
 
Event Description
It was reported that the bd facs¿ lyse wash assistant carried over contamination between samples.There was no adverse patient impact.The following information was provided by the initial reporter: "customer suspects a contamination between samples that is observable when acquiring tubes with the facscanto.The cytometer is clean and cst passes fine." were samples contaminated? yes.Are there erroneous results on patient samples for diagnostic test? no.Was there any delay of treatment due to the issue? no.If patient samples were redrawn, was there any change or delay of treatment? no.Was there any physical harm/injury to the patient due to the issue? no.
 
Manufacturer Narrative
H.6.Investigation: ¿ scope of issue: the scope of issue is only limited to bd facs lyse wash assistant, part # 337146 and serial # (b)(6).¿ problem statement: customer reported a complaint regarding sample carryover.¿ manufacturing defect trend: there are zero qns (quality notifications) related to the reported issue.Date range from 22oct2020 to 22oct2021.¿ complaint trend: there are 11 complaints related to the issue of sample carryover.Date range from 22oct2020 to 22oct2021.¿ manufacturing device history record (dhr) review: dhr part #337146 serial # (b)(6) , file # (b)(4), was reviewed.The instrument met all the manufacturing specifications prior to release.¿ investigation result / analysis: the investigation was performed and based on the review of the complaint trend, defect trend, dhr, risk analysis and servicemax, the root cause of the carryover between sample tests could not be determined.The customer had initially reported that they observed carryover between sample tests.The fse (field service engineer) that came onsite responding to the complaint ran several tests with the customer to observe the carryover, but the instrument was functioning as expected with no erroneous results.No parts were requested for evaluation as there were no parts replaced.Although the unexpected results were from patient samples, no patient was treated nor harmed from incorrect results.The results were captured prior to any diagnosis decision and was reported to bd as not expected.Proper daily and monthly cleaning procedures may help in reducing the chance of carryover, and can be found under ¿maintenance¿ in the user guide; bd facs¿ lyse wash assistant system instructions for use, #23-11113-01 rev.1/vers.A, page 111.The safety risk is moderate, s3, and there was no impact to patient health or safety.¿ service max review: review of related work order #: 02168973, case # (b)(4).Install date: 28mar2019.Defective part number: n/a.Work order notes: o subject / reported: 337146 - bd facs lyse wash assistant - carryover.O problem description: customer suspects a carryover between samples.When acquiring tubes with the cytometer, they see populations from the previous tubes.O work performed: lwa compliant.O cause: lwa.O solution: after several tests carried out with the client, everything seems normal to me.Support requested from the application service.¿ returned sample evaluation: a return sample was not requested because there were no parts replaced.¿ risk analysis: risk management file part # 337146ra, rev.02/vers.C, bd facs¿ lyse/wash assistant risk analysis was reviewed.No new hazards have been identified and the current mitigation is sufficient.Hazard(s) identified? yes or no.O id: (b)(6).O hazard: carryover.O cause: clogged orifice.O harmful effects: incorrect results, damaged instrument.O risk control: replace orifice at each pm interval.O implementation verification: reliability testing in sv lab; protocol: gppd0010-03 rev a.O effectiveness verification: system characterization summary report lwa carryover evaluation phase iii version 1.0 10/mar/2010.O probability: 1.O severity: 3.O risk index: 3.O residual risk evaluation: a.O new hazards: none.Mitigation(s) sufficient: yes or no? ¿ root cause: based on the investigation results the root cause of the carryover between samples could not be determined.¿ conclusion: based on the investigation results the root cause of the carryover between samples could not be determined.After receiving the customer complaint, an fse came onsite to confirm the issue.After running several tests with the customer, the fse determined that the instrument was functioning as expected with no erroneous results.No one was harmed or injured, and no medical diagnosis was performed due to the initial erroneous results.The safety risk is moderate, s3, and there was no impact to patient health or safety.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD FACS¿ LYSE WASH ASSISTANT
Type of Device
STATION, PIPETTING DILUTING CLINICAL USE
Manufacturer (Section D)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
2350 qume drive
san jose CA 95131
Manufacturer (Section G)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
2350 qume drive
san jose CA 95131
Manufacturer Contact
katie swenson
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key12835820
MDR Text Key280954292
Report Number2916837-2021-00445
Device Sequence Number1
Product Code JQW
UDI-Device Identifier00382903371464
UDI-Public00382903371464
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model Number337146
Device Catalogue Number337146
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/22/2021
Initial Date FDA Received11/18/2021
Supplement Dates Manufacturer Received01/05/2022
Supplement Dates FDA Received01/12/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/12/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-